Skip to main content

Table 3 Logistic regression analysis of the influencing factors of VMA changes

From: The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF

Variable

P-value

OR

CI (95%)

Gender

0.830

0.818

0.130

5.136

Age

0.217

1.106

0.943

1.297

Hypertension

0.598

0.589

0.082

4.215

Diabetes

0.420

0.329

0.022

4.916

Cataract surgery

0.283

4.000

0.319

50.228

Baseline VMIA

0.033

16.518

1.258

216.939

Baseline BCVA

0.237

0.184

0.011

3.037

Baseline CRT

0.337

1.003

0.997

1.008

Anti-VEGF drugs

0.928

1.098

0.144

8.382

Injection times before VMI change

0.546

1.333

0.524

3.389

Treatment time

0.068

0.750

0.551

1.021